Wouter van Rheenen

11.1k total citations
30 papers, 1.2k citations indexed

About

Wouter van Rheenen is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Wouter van Rheenen has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 19 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Wouter van Rheenen's work include Amyotrophic Lateral Sclerosis Research (20 papers), Neurogenetic and Muscular Disorders Research (19 papers) and Neurological diseases and metabolism (7 papers). Wouter van Rheenen is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (20 papers), Neurogenetic and Muscular Disorders Research (19 papers) and Neurological diseases and metabolism (7 papers). Wouter van Rheenen collaborates with scholars based in Netherlands, Australia and Belgium. Wouter van Rheenen's co-authors include Jan H. Veldink, Naomi R. Wray, Leonard H. van den Berg, Michael A. van Es, Andrew J. Schork, Sang Lee, Wouter J. Peyrot, Marianne de Visser, Helenius J. Schelhaas and Anneke J. van der Kooi and has published in prestigious journals such as Nature Communications, PLoS ONE and Nature Reviews Genetics.

In The Last Decade

Wouter van Rheenen

29 papers receiving 1.2k citations

Peers

Wouter van Rheenen
Colette Donaghy United Kingdom
Janet Cady United States
Alice Brockington United Kingdom
Jonathan A. Fidler United States
P. F. Chance United States
Carlo Wilke Germany
Wouter van Rheenen
Citations per year, relative to Wouter van Rheenen Wouter van Rheenen (= 1×) peers Lucia Corrado

Countries citing papers authored by Wouter van Rheenen

Since Specialization
Citations

This map shows the geographic impact of Wouter van Rheenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter van Rheenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter van Rheenen more than expected).

Fields of papers citing papers by Wouter van Rheenen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter van Rheenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter van Rheenen. The network helps show where Wouter van Rheenen may publish in the future.

Co-authorship network of co-authors of Wouter van Rheenen

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter van Rheenen. A scholar is included among the top collaborators of Wouter van Rheenen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter van Rheenen. Wouter van Rheenen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elferink, Martin, Paul J. Hop, Ramona A. J. Zwamborn, et al.. (2025). Comprehensive analysis across SMN2 excludes DNA methylation as an epigenetic biomarker for spinal muscular atrophy. iScience. 28(5). 112461–112461.
2.
Harley, Peter, Ruben P. A. van Eijk, Pavol Zelina, et al.. (2023). UNC13Ain amyotrophic lateral sclerosis: from genetic association to therapeutic target. Journal of Neurology Neurosurgery & Psychiatry. 94(8). 649–656. 25 indexed citations
3.
Wadman, Renske I., Wouter van Rheenen, W. Ludo van der Pol, & Leonard H. van den Berg. (2022). Major advances in neuromuscular disorders in the past two decades. The Lancet Neurology. 21(7). 585–587. 2 indexed citations
4.
Westeneng, Henk‐Jan, Rick A. A. van der Spek, Susan Peters, et al.. (2021). Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study. The Lancet Neurology. 20(5). 373–384. 37 indexed citations
5.
Trabjerg, Betina B., Fleur C. Garton, Wouter van Rheenen, et al.. (2020). ALS in Danish Registries. Neurology Genetics. 6(2). e398–e398. 23 indexed citations
6.
Baselmans, Bart M. L., Loïc Yengo, Wouter van Rheenen, & Naomi R. Wray. (2020). Risk in Relatives, Heritability, SNP-Based Heritability, and Genetic Correlations in Psychiatric Disorders: A Review. Biological Psychiatry. 89(1). 11–19. 62 indexed citations
7.
Spek, Rick A. A. van der, Wouter van Rheenen, Sara L. Pulit, et al.. (2019). The project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 20(5-6). 432–440. 41 indexed citations
8.
Dekker, Annelot M., Frank P. Diekstra, Sara L. Pulit, et al.. (2019). Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis. Scientific Reports. 9(1). 5931–5931. 11 indexed citations
9.
Rheenen, Wouter van, Wouter J. Peyrot, Andrew J. Schork, Sang Lee, & Naomi R. Wray. (2019). Genetic correlations of polygenic disease traits: from theory to practice. Nature Reviews Genetics. 20(10). 567–581. 196 indexed citations
10.
Rheenen, Wouter van, Frank P. Diekstra, Oliver Harschnitz, et al.. (2018). Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study. PLoS ONE. 13(6). e0198874–e0198874. 38 indexed citations
11.
Rheenen, Wouter van, et al.. (2017). Circulating microRNAs in patients with intracranial aneurysms. PLoS ONE. 12(5). e0176558–e0176558. 31 indexed citations
12.
Visser, Anne E, Raha Pazoki, Sara L. Pulit, et al.. (2017). No association between gluten sensitivity and amyotrophic lateral sclerosis. Journal of Neurology. 264(4). 694–700. 4 indexed citations
13.
Harschnitz, Oliver, Leonard H. van den Berg, Marc Jansen, et al.. (2016). Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell–derived model. Annals of Neurology. 80(1). 71–88. 46 indexed citations
14.
Dekker, Annelot M., Meinie Seelen, Perry T.C. van Doormaal, et al.. (2015). Large-scale screening in sporadic amyotrophic lateral sclerosis identifies genetic modifiers in C9orf72 repeat carriers. Neurobiology of Aging. 39. 220.e9–220.e15. 19 indexed citations
15.
Walhout, Renée, Ruben Schmidt, Henk-Jan Westeneng, et al.. (2015). Brain morphologic changes in asymptomatic C9orf72 repeat expansion carriers. Neurology. 85(20). 1780–1788. 58 indexed citations
16.
Blitterswijk, Marka van, Michael A. van Es, Max Koppers, et al.. (2012). VAPB and C9orf72 mutations in 1 familial amyotrophic lateral sclerosis patient. Neurobiology of Aging. 33(12). 2950.e1–2950.e4. 67 indexed citations
17.
Blitterswijk, Marka van, Michael A. van Es, Eric A. M. Hennekam, et al.. (2012). Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Human Molecular Genetics. 21(17). 3776–3784. 237 indexed citations
18.
Koppers, Max, Ewout J. N. Groen, Paul W.J. van Vught, et al.. (2012). Screening for rare variants in the coding region of ALS-associated genes at 9p21.2 and 19p13.3. Neurobiology of Aging. 34(5). 1518.e5–1518.e7. 14 indexed citations
19.
Groen, Ewout J. N., Wouter van Rheenen, Max Koppers, et al.. (2012). CGG-repeat expansion in FMR1 is not associated with amyotrophic lateral sclerosis. Neurobiology of Aging. 33(8). 1852.e1–1852.e3. 6 indexed citations
20.
Doormaal, Perry T.C. van, Wouter van Rheenen, Marka van Blitterswijk, et al.. (2012). UBQLN2 in familial amyotrophic lateral sclerosis in the Netherlands. Neurobiology of Aging. 33(9). 2233.e7–2233.e8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026